What is the normal value of cardiac troponin I (cTnI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Values of Cardiac Troponin I (cTnI)

The normal value of cardiac troponin I is defined by the 99th percentile upper reference limit, which varies by assay and ranges from approximately 10-60 ng/L depending on the specific high-sensitivity assay used, with sex-specific differences showing lower values in women (approximately 11-54 ng/L) compared to men (approximately 19-78 ng/L). 1

Assay-Specific Reference Values

The normal range for cTnI is highly dependent on the specific assay platform being used. The FDA-cleared high-sensitivity cardiac troponin I assays have the following 99th percentile upper reference limits 1:

  • Abbott ARCHITECT hs-cTnI: 28 ng/L overall (17 ng/L for females, 35 ng/L for males)
  • Beckman Coulter Access 2 hs-cTnI: 17.5-18.2 ng/L overall (11.6-11.8 ng/L for females, 19.7-19.8 ng/L for males)
  • Siemens ATELLICA hs-cTnI: 45.4 ng/L overall (38.6 ng/L for females, 53.5 ng/L for males)
  • Siemens ADVIA Centaur hs-cTnI: 46.5 ng/L overall (39.6 ng/L for females, 58.0 ng/L for males)
  • Siemens Dimension VISTA hs-cTnI: 58.9 ng/L overall (53.7 ng/L for females, 78.5 ng/L for males)
  • Siemens Dimension ExL hs-cTnI: 60.4 ng/L overall (51.4 ng/L for females, 76.2 ng/L for males)

Key Clinical Thresholds

Values below the 99th percentile are considered normal, though even detectable levels below this threshold may have prognostic significance 1. The Third Universal Definition of Myocardial Infarction establishes that any elevation above the 99th percentile URL indicates myocardial injury 1.

Important Measurement Considerations:

  • Limit of Detection (LoD): Ranges from 1.0-3.0 ng/L depending on assay 1
  • Limit of Quantitation (LoQ): Ranges from 0.9-6.0 ng/L depending on assay 1
  • Measurability: High-sensitivity assays can detect cTnI in >95% of healthy individuals 2

Age-Related Variations

Pediatric populations have significantly different reference ranges. In neonates and infants, the 99th percentile values are markedly elevated and decline progressively during the first year of life 3:

  • Newborns (0-30 days): 114 ng/L
  • 1 month (31-60 days): 65.6 ng/L
  • 2 months (61-90 days): 55.2 ng/L
  • 3-4 months: 30.4 ng/L
  • 5-6 months: 23.5 ng/L
  • 7-12 months: 12.7 ng/L

Clinical Context for Interpretation

Values must be interpreted in clinical context, as elevations can occur in conditions other than acute myocardial infarction. In the pulmonary embolism literature, various cutoff values have been used for risk stratification, ranging from 0.01 ng/mL to 2.3 μg/L, though these represent pathological elevations rather than normal values 1.

Common Pitfalls:

  • Assay-specific differences: Never apply reference ranges from one assay to results from another assay 1
  • Sex differences: Failing to use sex-specific cutoffs may lead to overdiagnosis in men and underdiagnosis in women 1
  • Chronic kidney disease: Patients with advanced CKD frequently have elevated baseline troponin levels that may not represent acute myocardial injury 4
  • Post-exercise elevation: High-intensity exercise can cause transient troponin elevation even in healthy individuals, with levels peaking at 3 hours and normalizing by 24 hours 5

For clinical decision-making, always verify the specific 99th percentile URL for your institution's assay platform and apply sex-specific cutoffs when available 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.